Glycopolymers for Efficient Inhibition of Galectin-3: In Vitro Proof of Efficacy Using Suppression of T Lymphocyte Apoptosis and Tumor Cell Migration
Marina Rodrigues Tavares,Ladislav Bumba,Lothar Elling,Petr Chytil,Marcela Filipová,Pavla Bojarová,Kristýna Gunár,Vladimír Křen,Tomáš Etrych,Olga Janoušková
DOI: https://doi.org/10.1021/acs.biomac.0c00515
2020-07-22
Biomacromolecules
Abstract:The development of efficient galectin-3 (Gal-3) inhibitors draws attention in the field of anti-cancer therapy, especially due to the prominent role of extra- and intracellular Gal-3 in vital processes of cancerogenesis, such as immunosuppression, stimulation of tumor cells proliferation, survival, invasion, apoptotic resistance, and metastasis formation and progression. Here, by combining poly-LacNAc (Galβ4GlcNAc)-derived oligosaccharides with <i>N</i>-(2-hydroxypropyl) methacrylamide (HPMA) copolymers, we synthesized multivalent glycopolymer inhibitors with a high potential to target extracellular and intracellular Gal-3. The inhibitory capabilities of the best conjugate in the studied series were in the nanomolar range proving the excellent Gal-3 inhibitory potential. Moreover, thorough investigation of the inhibitory effect in the biological conditions showed that the glycopolymers strongly inhibited Gal-3-induced apoptosis of T lymphocytes and suppressed migration and spreading of colorectal, breast, melanoma, and prostate cancer cells. In sum, the strong inhibitory activity toward Gal-3, combined with favorable pharmacokinetics of HPMA copolymers ensuring enhanced tumor accumulation <i>via</i> the enhanced permeability and retention effect, nominate the glycopolymers containing LacdiNAc-LacNAc (GalNAcβ4GlcNAcβ3Galβ4GlcNAc) tetrasaccharide as promising tools for preclinical in anti-cancer therapy evaluation.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.biomac.0c00515?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.biomac.0c00515</a>.Analytical methods; synthesis of functionalized carbohydrate ligands; MS spectra of functionalized carbohydrate ligands; detailed synthesis of polymer precursor <b>6</b>; detailed synthesis of glycopolymer <b>17</b>; characterization of polymer precursors and glycopolymers; NMR spectra of glycopolymers <b>9</b>, <b>12</b>, and <b>17</b>; inhibition of Gal-3 binding by glycopolymers; and Gal-3 expression in cancer cell lines (<a class="ext-link" href="/doi/suppl/10.1021/acs.biomac.0c00515/suppl_file/bm0c00515_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
polymer science,biochemistry & molecular biology,chemistry, organic